Darmstadt, Germany, March 31, 2021 — Merck, a leading science and technology company, today announced a strategic partnership with the Faculty of Mathematics and Natural Sciences, Universitas Indonesia (FMIPA-UI) to establish the first Collaboration Laboratory between the company and the university to advance life science research and innovation development in Indonesia.
“Universitas Indonesia is one of our country’s most prominent research centers,” said Christopher Thomas, president director of PT Merck Chemicals and Life Sciences. “We look forward to our support empowering young researchers to produce world-quality life science research and breakthroughs.”
The collaboration is expected to provide IDR 3 billion worth of advanced laboratory tools, equipment, and expertise and is aimed at strengthening research in the areas of environmental monitoring, chemical analysis, microbiology, and molecular biology, as well as innovations in food, agriculture, and waste management. Merck will implement a continuous mentoring process and a series of workshops and seminars to transfer knowledge and expertise to Universitas Indonesia scientists and academics.
“Universitas Indonesia and Merck’s partnership is a demonstration of triple helix collaboration between industry, academia, and government,” said Professor Bambang Permadi Soemantri Brodjonegoro, Ph.D., minister of Research and Technology of the Republic of Indonesia / National Research and Innovation Agency. “We always support cooperation that fosters the world of research and innovation in Indonesia. We hope what Merck and Universitas Indonesia are doing will trigger more collaborations in this country, especially in life science.”
Rector Universitas Indonesia Professor Ari Kuncoro, S.E., M.A., Ph.D., welcomes collaboration and Merck’s initiative to build a Collaboration Lab at FMIPA-UI.
“Being able to collaborate with Merck as one of the world’s leading science and technology companies is an honor for the entire academic community of Universitas Indonesia,” Kuncoro said. “Merck’s support will further encourage FMIPA-UI in its vision of becoming a leading mathematics and science faculty that has the global capability to foster sustainable science and development.”
Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck generated sales of €16.2 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science and EMD Performance Materials.